Clauw, who serves as director of the University of Michigans Chronic Pain and Fatigue Research Center
Treatment Plan: If youre a good candidate, theyll offer a single shot or a "loading course" a series of injections over a few weeks followed by regular maintenance top-ups
Because AOD-9604 works peripherally on fat tissue through beta-3 adrenergic receptors without affecting central appetite pathways, there is no adaptation of hunger-regulating systems and therefore no rebound effect when stopping
Inject at room temperaturecold peptide solution causes localized vasoconstriction, reducing absorption rate and increasing discomfort
This takes 30 to 60 seconds
Unlike full-length growth hormone, which can stimulate appetite through IGF-1 production and growth hormone receptor activation, AOD-9604 does not activate the growth hormone/IGF-1 pathway